Ematologia di precisione: linfoma a grandi cellule B

🛎️ Don't miss our videos, subscribe to the channel, and activate the bell to receive notifications about new content! 🛎️ Precision hematology is the focus of the AIL campaign during Blood Cancer Awareness Month. This interview focuses on large B-cell lymphoma, with Professor Paolo Corradini, a leading expert in the field of hematological malignancies, discussing advances in lymphoma treatment, emphasizing the importance of monoclonal antibodies and so-called small molecules in providing significant benefits in the treatment of aggressive lymphoma. The interview highlights potentially promising new treatments, including the use of novel antibodies that work by binding a toxin to tumor cells, causing their death. Professor Corradini also discusses new treatment options, including more specific antibodies and CAR-T therapies targeting the CD19 antigen. While these therapies do not replace existing treatments, they represent a significant addition to available options. Professor Corradini concludes with an analysis of the future of lymphoma treatment, highlighting the arrival of new antibodies and bispecific antibodies, as well as the approval and availability of CAR-T therapies in Italy and Europe. The discussion highlights the significant evolution underway in lymphoma treatment, offering hope and new options for patients affected by this disease. #lymphoma #hematology #oncology ************************ 🔥 Follow us! Magazine: https://www.PianetaSalute.online IG:   / pianetasalute2.0   Twitter:   / pianetasalute   Facebook:   / pianetasalute   Linkedin:   / pianeta-salute-agenzia-di-stampa-tv   WhatsApp: https://whatsapp.com/channel/0029VaDP... CHAPTERS 00:00 Hematologic Cancer Awareness Month 00:38 Introduction to Large B-Cell Lymphoma 01:10 Treatment of Large B-Cell Lymphoma 02:38 New Antibodies 04:01 T-Cell-Based Therapies 05:13 Future Therapies and Approvals 06:30 Bispecific Antibody Therapy 07:43 Expansion of Treatment Options 08:00 CAR-T